Concord Drugs Ltd Schedules AGM for September 30, 2026

Concord Drugs Ltd has announced that its Annual General Meeting (AGM) will be held on September 30, 2026, at 09:30 AM. The meeting will be conducted via Video Conference/Other Audio-Visual Means, in compliance with MCA and SEBI circulars. The company is also submitting its Annual Report and Notice of AGM for the Financial Year 2025-26, which will be sent electronically to members with registered email addresses. A weblink to access the Annual Report will be provided to members whose email addresses are not registered. The AGM will transact ordinary business, including the adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026.